Phages, anti-CRISPR proteins, and drug-resistant bacteria: what do we know about this triad?
Pathogens and Disease · 29.10.2022 · 80 (1)
DOI: 10.1093/femspd/ftac039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens and Disease, online erschienen am 18.10.2022. Verfasst von Andres Ceballos-Garzon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Université Clermont Auvergne, INRAE, MEDiS, 63000 Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Bacteriophages. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 117 Literaturangaben.
Abstract (Originalsprache)
Phages are viruses that infect bacteria, relying on their genetic machinery to replicate. To survive the constant attack of phages, bacteria have developed diverse defense strategies to act against them. Nevertheless, phages rapidly co-evolve to overcome these barriers, resulting in a constant, and often surprising, molecular arms race. Thus, some phages have evolved protein inhibitors known as anti-CRISPRs (∼50–150 amino acids), which antagonize the bacterial CRISPR-Cas immune response. To date, around 45 anti-CRISPRs proteins with different mechanisms and structures have been discovered against the CRISPR-Cas type I and type II present in important animal and human pathogens such as Escherichia, Morganella, Klebsiella, Enterococcus, Pseudomonas, Staphylococcus, and Salmonella. Considering the alarming growth of antibiotic resistance, phage therapy, either alone or in combination with antibiotics, appears to be a promising alternative for the treatment of many bacterial infections. In this review, we illustrated the biological and clinical aspects of using phage therapy; furthermore, the CRISPR-Cas mechanism, and the interesting activity of anti-CRISPR proteins as a possible weapon to combat bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Clermont Auvergne, INRAE, MEDiS, 63000 Clermont-Ferrand, France.
- Biotecnología y Genética S.A.S - Línea de enfermedades infecciosas y microbiología molecular, Colombia.
- Infectious diseases department, Fundación Santa Fe, 110111 Bogotá, Colombia.
- Grupo de Investigación Gestión Ambiental, Facultad de Ciencias e Ingeniería, Departamento de Biología y Microbiología, Universidad de Boyacá, 150003 Tunja- Boyacá, Colombia.
- Research Group on Foods, Nutritional Biochemistry and Health, Universidad Europea del Atlántico, Santander 39011, Spain.
- CIBER of Infectious Diseases-CIBERINFEC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: Andres Ceballos-Garzon, Jose Ramos-Vivas
Zitieren
APA
Ceballos-Garzon, A., Muñoz, A. B., Plata, J. D., Sanchez-Quitian, Z. A., & Ramos-Vivas, J. (2022). Phages, anti-CRISPR proteins, and drug-resistant bacteria: what do we know about this triad?. Pathogens and Disease, 80(1). https://doi.org/10.1093/femspd/ftac039
Vancouver
Ceballos-Garzon A, Muñoz AB, Plata JD, Sanchez-Quitian ZA, Ramos-Vivas J. Phages, anti-CRISPR proteins, and drug-resistant bacteria: what do we know about this triad?. Pathogens and Disease. 2022;80(1). doi:10.1093/femspd/ftac039
BibTeX
@article{CeballosGarzon2022,
author = {Ceballos-Garzon, Andres and Muñoz, Angela B and Plata, Juan D and Sanchez-Quitian, Zilpa A and Ramos-Vivas, Jose},
title = {Phages, anti-CRISPR proteins, and drug-resistant bacteria: what do we know about this triad?},
journal = {Pathogens and Disease},
year = {2022},
volume = {80},
number = {1},
doi = {10.1093/femspd/ftac039}
}
EUVIMED